Biosimilar vs Red Book Peds ID Chart
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Biosimilar
This app serves as a reference for biosimilar and interchangeable biologic drugs, drawing from the FDA's Purple Book. It offers essential prescribing and dispensing information for healthcare professionals managing complex drug therapeutics.
- FDA Purple Book reference
- Prescribing information
- Dispensing guidance
- Biologic drug data
- Interchangeable product details
Read full descriptionHide full description
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics. ** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
Red Book Peds ID Chart
Read full descriptionHide full description
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content. The fully revised Red Book Pediatric Infectious Diseases Clinical Decision Support Chart, 3rd edition chart distills essential tables and algorithms from the Red Book, 33rd Edition into a colorful, enlarged, easy-to-navigate format. Designed for quick clinical reference, it includes new, exclusive tables synthesizing key guidance on immunizations, antibiotic prophylaxis, immune globulin, and major pediatric infections—such as staphylococcal and streptococcal disease, COVID-19/MIS-C, tuberculosis, Lyme disease, HIV, and care of immunocompromised children and adolescents. Fully revised and updated, the third edition of this full-color chart collects many of the most clinically useful tables, algorithms, and other items from the Red Book, 33rd Edition and presents them in an enlarged, enhanced colorized format that is lightweight, portable, and easy to navigate. Additionally, new tables have been created exclusively for this chart, synthesizing important clinical information from the Red Book text. Topics include: - Staphylococcal Infections - Streptococcal Infections - COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) - Diarrheal Infections - Immunizations - Antibiotic Prophylaxis - Immune Globulin - Kawasaki Disease - Tuberculosis - Lyme Disease - Varicella-Zoster - Fungal Infections - Genital and Neonatal Herpes - Syphilis - HIV - Immunocompromised Children and Adolescents Content licensed from printed ISBN 10: 1610027426 & ISBN 13: 9781610027427 If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): David W. Kimberlin, MD, FAAP Publisher: American Academy of Pediatrics
Screenshots
Verdict
The clearest difference is price: Red Book Peds ID Chart at Free against Biosimilar's $1.99. Red Book Peds ID Chart also leads on iOS requirement (13.0 vs 17.6). Biosimilar's advantage is in-app purchases (none vs 1) and ads (none vs shown). On device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Red Book Peds ID Chart is free to download; Biosimilar costs $1.99 up front. Red Book Peds ID Chart sells 1 one-off in-app purchase. Biosimilar asks for nothing beyond the download.
| Parameter | Biosimilar | Red Book Peds ID Chart |
|---|---|---|
| Price | $1.99 | Free — better |
| Rating | 5.0 (2 ratings) — better | — |
| Number of ratings | 2 — better | — |
| Update frequency | Every 3 months | — |
| Ads | No — better | Yes |
| In-app purchases | No — better | Yes |
| Monetization | Paid | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 17.6 | 13.0 — better |
| Further details — not scored | ||
| Size | 2 MB | 150 MB |
| Age rating | 17+ | 17+ |
| Developer | Dabbling Badger LLC | Skyscape Medpresso Inc |
In-app purchases
Biosimilar
No in-app purchases
Red Book Peds ID Chart
- Red Book Pediatric Infect. Diseases$49.95
Questions
Is Biosimilar free?
Is Red Book Peds ID Chart free?
Do Biosimilar or Red Book Peds ID Chart have ads?
Other comparisons















